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Collecting Saliva Samples by Mail
Jean-Frangois Etter, Thomas V. Perneger, and Anne Ronchi
Collecting saliva samples by mail can serve numerous purposes in epidemiologic research. The objectives
of this study were to assess what proportion of participants in a mail survey would provide a saliva sample and
whether incentives could improve participation. In 1995,2,994 students, faculty, and staff members of Geneva
University, Geneva, Switzerland, were randomized to receive, together with a mailed questionnaire about
smoking, a saliva vial, a ballpoint pen, the offer of a lottery, or any combination of these. After one mailing and
a reminder letter, response rates were 52% among those who had been requested to provide saliva and 63%
among controls (p < 0.001). In the former group, most respondents (98%) provided a saliva sample. Incentives
improved participation only among those who were asked to provide saliva (lottery: +11% response, p =
0.003; pen: +6% response, p = 0.1). The final participation, after up to three reminders, was 76% overall. The
authors conclude that while the collection of saliva samples by mail is feasible it tends to decrease response
rates. Am J Epidemiol 1998;147:141-6.
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specimen handling
Collecting saliva samples by mail can serve numer-
ous purposes in epidemiologic research, including
measurement of cotinine, a metabolite of nicotine ( 1 -
3). Cotinine is stable in unrefrigerated saliva (4), even
when samples are collected by mail and remain unfro-
zen for 12 days (5, 6). Collection of saliva samples by
mail costs four times less than collection at the par-
ticipant's workplace (6). Other substances that are
stable in unrefrigerated saliva and could be collected
by mail include thiocyanate (7, 8), genetic materials
(9), testosterone (10), and human immunodeficiency
virus (HIV) antibodies (11, 12).
Despite the potential benefits of collecting saliva
samples by mail, to our knowledge, only studies of
technical feasibility have so far been conducted (7-
11). A possible concern is that requesting saliva sam-
ples may reduce response rates, but no evidence exists
regarding this issue (13). We aimed to establish what
proportion of potential respondents to a mailed survey
about smoking would agree to provide a saliva sample,
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and whether requesting saliva affects the response
rate.
Various incentives may increase response to mailed
surveys (14), such as offering a pen (15-17) or par-
ticipation in a lottery (18-22). Our second aim was to
assess whether response rates could be increased by
offering participation in a lottery and/or a ballpoint
pen.
Finally, asking participants to provide saliva or of-
fering incentives could bias results, either by modify-
ing response rates in population subgroups (selection
bias) or by altering respondents' answers (information
bias). Our third objective was to establish whether
such procedure-related bias occurred.
MATERIALS AND METHODS
Study setting and population
The study population (n = 9,686) included students
(82 percent), faculty (12 percent), and administrative
and technical staff (6 percent) of the University of
Geneva, Geneva, Switzerland. A simple random sam-
ple of 3,000 persons was drawn from the university
files. This file indicated the address, birth date, and sex
of each participant. The study was approved by the
review board of the Institute of Social and Preventive
Medicine of the University of Geneva.
141
142 Etteretal.
Study design
Potential participants were randomized in a three-
way factorial trial of the following interventions:
1) request to provide a saliva sample, 2) inclusion of a
ballpoint pen (value <$1), and 3) offer to participate
in a lottery if the questionnaire was returned. Lottery
prizes were a weekend in Paris for two persons (valued
at $540) and nine vouchers for books (valued at $40
each). Randomization resulted in groups of similar age
(mean age, 29 years) and sex (men, 42 percent). After
deletion of six names that appeared twice, the survey
package was mailed to 2,994 persons in November
1995.
was of interest. We planned to collect saliva only in
the initial mailing, because our resources allowed lab-
oratory analysis only of a limited number of samples.
A reminder postcard was sent 2 days after the first
mailing (29), and a reminder letter was sent to all
nonrespondents after 15 days, without the question-
naire or saliva vial. The randomized intervention was
interrupted on day 28 of data collection. To maximize
the final response rate, all reminder packages sent to
nonrespondents after day 28 included both incentives.
Data collection ended 121 days after the initial mail-
ing, when up to four survey packages had been sent to
nonrespondents.
Data collection
The initial mailing contained the questionnaire, a
cover letter explaining the purpose of the study, and a
business reply envelope. Questions covered smoking
history, exposure to environmental tobacco smoke,
health status (SF-36 "general health" scale (23, 24)),
stages of change of smoking (25) and, for smokers
only, the pros and cons of smoking (26), level of
nicotine dependence (27), and smoking self-efficacy
(28). The date when the questionnaire was mailed
back was assessed by the post office date of cancella-
tion on the envelope.
Saliva was collected in a plastic vial containing a
sterile dental cotton roll (Salivette, Sarstedt, Niim-
brecht, Germany, article no. 511534). The cover letter
indicated that nonsmokers too should provide saliva,
because exposure to environmental tobacco smoke
Analysis
Separate analyses were conducted for the "random-
ized phase" (days 1-28), the "most effective interven-
tion phase" (days 29-121), and overall (days 1-121).
At the end of the "randomized phase," we assessed
selection bias by comparing response rates by age and
sex across randomized groups; interactions between
demographic variables and incentives were tested in
logistic regression models with interaction terms (30).
We also examined procedure-related bias by compar-
ing respondent characteristics across randomized
groups. We also compared participants who responded
during the "randomized phase" and the "most effective
intervention phase." Finally, we compared delays be-
tween the initial mailing and the return of the ques-
tionnaire among subgroups of respondents. Participa-
tion was described using Kaplan-Meier curves (30).
TABLE 1. Response rates to a mailed questionnaire in a three-way factorial randomized trial of requesting a saliva sample,
offering a lottery and a ballpoint pen, Geneva, Switzerland, 1995
Incentives
All participants
Cflih/a vialOailvd Vial
Yes
No
Ballpoint pen
Yes
No
Lottery
Yes
No
Incentive group
1. Saliva vial + lottery + pen
2. Saliva vial + pen
3. Saliva vial + lottery
4. Saliva vial
5. Lottery + pen
6. Pen
7. Lottery
8. None
Randomized Intervention phase
(days 1-28)
Total
2,994
1,496
1.498
1,497
1,497
1,497
1,497
365
361
391
379
374
397
367
360
No.
who
responded
1,733
785
948
889
844
902
831
209
185
219
172
242
253
232
221
%
57.9
52.5
63.3
59.4
56.4
60.3
55.5
57.3
51.2
56.0
45.4
64.7
63.7
63.2
61.4
P
value
-
<0.001
0.10
0.009
0.001*
0.11*
0.O03*
<0.001t
0.35t
0.511
0.61 f
-
No request tor saliva;
lottery and pen Included tor all
(days 29-121)
Total
1,173
661
512
567
606
559
614
148
161
162
190
122
136
127
127
No.
who
responded
523
262
261
239
284
242
281
52
58
65
87
62
67
63
69
%
44.6
39.6
51.0
42.2
46.9
43.3
45.8
35.1
36.0
40.1
45.8
50.8
49.3
49.6
54.3
P
value
-
< 0.001
0.10
0.39
0.05*
0.06*
0.28*
0.14t
0.58t
0.411
0.45t
-
Overall
(days 1-121)
No.
who
responded
2,272
1,055
1,217
1,134
1,138
1,152
1,120
261
246
285
263
307
320
299
291
%
75.9
70.5
81.2
75.8
76.0
76.9
74.8
71.5
68.1
72.9
69.4
82.1
80.6
81.5
80.8
P
value
-
<0.001
0.87
0.17
0.53*
0.71*
0.28*
<0.001t
0.66t
0.94t
0.83t
-
• Difference with group 4 (saliva vial only).
t Difference with group 8 (no Incentive or saliva vial).
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FIGURE 1. Cumulated nonresponse rate to a mail survey in eight
randomized groups, Geneva, Switzerland, 1995. The individuals in
the eight groups were requested to provide a saliva sample (A) or no
saliva sample (B), and received the following incentives: lottery and
ballpoint pen (heavy dashed line), lottery only (light solid line), pen
only (light dashed line), or no incentive (heavy solid line).
RESULTS
Response rates
During the "randomized phase," including a saliva
vial in the survey package decreased the response rate
by 11 percent (table 1). Almost all participants in the
saliva vial group (769 out of 785 (98 percent)) also
returned the saliva sample.
In the saliva vial group, during the "randomized
phase," both the lottery (+11 percent) and the pen (+6
percent) improved response rates, but this trend lacked
statistical significance. Cumulative incentives was
hardly better than the lottery alone (+1 percent).
When no saliva sample was requested, incentives had
no statistically significant effects on response rates
(table 1).
During the "most effective intervention phase," per-
sons who had received a saliva vial with the first
survey package had persistently lower response rates,
even when they were no longer reminded to provide
saliva. Persons who received incentives for the first
time on day 29 had higher response rates that persons
who had already received these incentives with the
first survey package.
Response delay among respondents
Respondents in the saliva vial group returned the
questionnaire on average 2 days later than controls (19
vs. 17 days, p = 0.009) (figure 1). The lottery accel-
erated response only in the saliva vial group (—2.6
days, p = 0.03). Effects of the pen, age, and sex were
nonsignificant.
Incentive-related selection bias. In the "random-
ized phase," increasing age was significantly nega-
tively associated with response rate, regardless of in-
centive group (table 2). The impact on response rates
of a saliva sample request was stronger in women
(-13.7 percent) than in men (—6.7 percent, between-
sex difference; p — 0.04). The response rate was
similar in men and women in the saliva vial group, but
it was lower in men than in women in the control
group. The lottery and the pen had similar effects on
response in men and women and across age groups.
Procedure-related bias. At the end of the "ran-
domized phase," respondents in the saliva vial group
were similar to controls in terms of age, sex, level of
education, health status, proportion of smokers, and
stages of change (table 3). Among smokers, the two
groups had similar scores on the nicotine dependence
test, the pros and cons of smoking, and self-efficacy.
Smokers who had been asked to provide saliva re-
ported smoking on average 1.4 fewer cigarettes per
day than controls, but the difference was not statisti-
cally significant. Answers were similar in groups de-
fined by receipt of incentives (data not shown).
Early vs. late respondents
The proportion of smokers was 6 percent lower
among persons who returned the questionnaire during
the "randomized phase" than among persons who re-
turned it later (table 3). In all other respects, early and
late respondents were similar.
DISCUSSION
In a mail survey of university students, faculty, and
staff, half the potential participants provided a saliva
sample after an initial mailing, reminder postcard, and
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TABLE 2. Response rates to a mailed questionnaire after one mailing and a reminder letter
("randomized phase"), according to sex, age, and three randomly allocated incentives, Geneva,
Switzerland, 1995
Sex Age
Men Women Pvalue*
Change in
response
ratef
P
value
Ail participants
Saliva vial
Yes
No
Ballpoint pen
Yes
No
Lottery
Yes
No
Incentive groups
1. Saliva vial + lottery + pen
2. Saliva vial + pen
3. Saliva vial + lottery
4. Saliva vial
5. Lottery + pen
6. Pen
7. Lottery
8. None
54.2 60.6 < 0.001 -4.6 < 0.001
50.9
57.6
55.7
52.6
57.6
50.8
55.4
48.1
57.1
42.1
60.0
59.2
57.7
53.0
53.7
67.4
62.1
59.1
62.2
58.9
58.5
53.7
55.1
47.6
68.2
67.1
67.0
67.3
0.29
<0.001
0.01
0.01
0.07
0.002
0.55
0.29
0.68
0.29
0.10
0.10
0.07
0.006
-4.7
-4.4
-3.4
-5.8
-3.8
-5.6
-5.1
-1.7
-5.3
-6.6
-1.7
-3.4
-8.0
-4.9
0.02
0.01
0.08
0.002
0.04
0.006
0.07
0.54
0.04
0.02
0.52
0.20
0.003
0.08
* Chi-square test.
t Change in response rate (percent) for a 10-year increase in age (linear regression).
TABLE 3. Impact of request to provide a saliva sample on the information obtained from a mailed
questionnaire among persons who returned the questionnaire during the "randomized phase,"
Geneva, Switzerland, 1995
Respondent
characteristics
No.
Men (%)
Mean age (years)
Education (years)
SF-36 "general health" scaled
Stages of change
Precontemplation (%)
Contemplation (%)
Preparation (%)
Action (%)
Maintenance (%)
Current smokers (%)
Among current smokers
Cigarettes per day
Nicotine dependence§
Pros of smokingH
Cons of smoking!
Self-efficacy!
Missing answers (%)
Randomized phase
Requested to provide
a saliva sample
Yes
785
41.0
28.4
17.3
76.3
46.2
12.5
5.0
12.9
23.4
27.1
10.7
1.85
50.0
49.8
50.8
11.8
No
948
38.0
28.6
17.3
76.2
46.9
12.8
4.9
12.2
23.2
27.9
12.2
2.04
50.7
50.4
49.4
11.9
P
value*
-
0.20
0.63
0.87
0.98
1.0
0.69
0.07
0.36
0.48
0.57
0.08
0.86
Most effective
Intervention phase
All
539
43.6
28.6
17.7
75.3
49.4
15.4
5.7
13.4
16.2
33.8
11.4
1.91
49.1
49.8
50.7
11.7
P
valuet
-
0.09
0.89
0.05
0.29
0.21
0.005
0.84
0.79
0.14
0.68
0.26
0.82
* p value on difference between saliva and no-saliva groups during randomized phase,
t p value on difference between persons who returned the questionnaire during the randomized phase and
persons who returned it during the best intervention phase.
$ Scaled between 0 (worst) and 100 (best) (23, 24).
§ Fagerstrom test, mean score between 0 (least dependent) and 10 (most dependent).
I Mean scores, standardized to mean = 50 and standard deviation = 10.
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reminder letter. Requesting a saliva sample reduced
the initial response rate to the questionnaire; because
we asked for a saliva sample only in the first mailing,
we do not know how much repeated requests for saliva
would have affected the final response rate. When a
saliva sample was requested, offering a pen or partic-
ipation in a lottery increased returns of questionnaires
and saliva vials.
The request for a saliva sample may reduce partic-
ipation for several reasons. First, asking for a biologic
sample may irretrievably antagonize some potential
participants. This hypothesis is suggested by persis-
tently lower participation rates among persons who
had received a" saliva vial in the first mailing, even
after requests for saliva samples were discontinued. A
better explanation of the purpose of the study may
alleviate this problem. Second, some persons may
have been concerned about confidential handling of
the samples (for instance, some may have feared that
drug or HIV tests would be performed). We have no
evidence that this occurred, but better explanations
and an anonymous data collection procedure may min-
imize such concerns. Third, the fact that incentives
were effective only in the saliva group suggests that
some people failed to return the saliva vial because
they did not receive any compensation in exchange for
their collaboration. Only this barrier can be overcome
by appropriate incentives. However, what incentives
to choose remains an open question.
Results observed among persons who were not re-
quested to provide saliva are consistent with previous
studies which showed that a lottery ticket (18) and a
raffle (19) have little influence on response rates, but
conflict with the findings of others (20-22). Inconsis-
tencies between studies suggest that incentives should
be tailored to particular study groups. The choice of
incentives may be optimized by appropriate pretests
(20, 31). One option worth exploring is whether prom-
ising to inform participants of their laboratory result
would increase their willingness to provide a saliva
sample.
In view of the reduced participation caused by saliva
sample requests, an important result is that such a
request did not cause bias, particularly regarding
smoking-related information. In adolescent popula-
tions, saliva collection is sometimes used to increase
the sincerity of answers (32, 33); in the adult popula-
tion that we studied, this would be unnecessary. The
selection bias associated with the timing of response
(higher proportion of smokers among late respon-
dents) was unrelated to saliva sample requests.
Several features of this study may limit its general-
izability. First, we studied a highly educated popula-
tion, and participation in mail surveys increases with
education level (34, 35). Therefore, our response rates
were probably higher than those that could be ex-
pected in general population surveys. Moreover, the
survey was sponsored by a university, which also
increases participation (36, 37). Finally, populations of
other countries may react differently to request for
saliva samples, for various cultural reasons. Neverthe-
less, the feasibility of collecting saliva samples by
mail opens promising perspectives in epidemiologic
research.
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